Progress in Neuro-Psychopharmacology & Biological Psychiatry

{{Infobox journal

| title = Progress in Neuro-Psychopharmacology & Biological Psychiatry

| cover =

| former_name = Progress in Neuro-Psychopharmacology

| abbreviation = Prog. Neuro-Psychopharmacol. Biol. Psychiatry

| discipline = Neuropsychopharmacology, biological psychiatry

| editor = Louis Gendron

| publisher = Elsevier

| country =

| history = 1977-present

| frequency = 8/year

| openaccess =

| license =

| impact = 5.6

| impact-year = 2022

| ISSN = 0278-5846

| eISSN = 1878-4216

| CODEN = PNPPD7

| JSTOR =

| LCCN =

| OCLC = 848644184

| website = http://www.journals.elsevier.com/progress-in-neuro-psychopharmacology-and-biological-psychiatry/

| link1 = http://www.sciencedirect.com/science/journal/02785846

| link1-name = Online archive

| link2 =

| link2-name =

}}

Progress in Neuro-Psychopharmacology & Biological Psychiatry is a peer-reviewed academic journal publishing review articles and original research reports pertaining to neuropsychopharmacology and biological psychiatry.

Background

The journal was established in 1977 as Progress in Neuro-Psychopharmacology, obtaining its current name in 1982.{{cite web |url=https://www.ncbi.nlm.nih.gov/nlmcatalog/7708294 |title=Progress in Neuro-Psychopharmacology |work=NLM Catalog |accessdate=12 September 2015}}{{cite web |url=https://www.ncbi.nlm.nih.gov/nlmcatalog/8211617 |title=Progress in Neuro-Psychopharmacology & Biological Psychiatry |work=NLM Catalog |accessdate=12 September 2015}} It is published eight times per year by Elsevier. The editor-in-chief is Louis Gendron (Université de Sherbrooke). According to the Journal Citation Reports, the journal has a 2022 impact factor of 5.6.{{cite book |year=2023 |chapter=Progress in Neuro-Psychopharmacology & Biological Psychiatry |title=2022 Journal Citation Reports |publisher=Clarivate Analytics |edition=Science |series=Web of Science |title-link=Journal Citation Reports}}

References

{{Reflist}}